Immune Checkpoint Inhibitors: A Promising Avenue in Precision Medicine
The immune checkpoint inhibitors market is estimated to be worth $12 billion in 2030 and is expected to grow at CAGR of 15% during the forecast period.
Cancer is known to be one of the leading causes of death worldwide, accounting for 0.6 million deaths in 2019, in the US alone.
To know more about the report, visit @ https://www.rootsanalysis.com/reports/immune-checkpoint-inhibitors/303.html